Abstract
To determine whether noradrenergic nerves might have a modulatory role on the sensitivity or reactivity of histaminergic receptor systems in brain, behavioral effects of the respective histamine H1, H2 and H3 antagonists S(+)chlorpheniramine, cimetidine and thioperimide in control adult rats were compared to the effects in adult rats that had been lesioned as neonates with the noradrenergic neurotoxin DSP-4. On the 1st and 3rd days after birth rat pups were treated with either saline or DSP-4 (50 mg/kg sc), then returned to their home cages with the dam. At 8 weeks when rats were tested, S(+)chlorpheniramine (10 mg/kg ip) was found to increase locomotor activity in intact and DSP-4 lesioned rats, while cimetidine (5 mg/kg, ip) and thioperimide (5 mg/kg, ip) increased activity severalfold solely in the DSP-4 group. Exploratory activity, nociceptive activity, and irritability were little altered by the histamine antagonists, although oral activity was increased by thioperimide in intact and lesioned rats, and by cimetidine or S(+)chlorpheniramine in DSP-4 rats. High performance liquid chromatography with electrochemical detection was used to determine that DSP-4 produced a 90% reduction in frontal cortex, hippocampus and hypothalamus, with a 90% elevation of NE in cerebellum — reflecting reactive sprouting of noradrenergic fibers consequent to lesion of noradrenergic tracts projecting to proximal brain regions. These findings indicate that perinatal noradrenergic fiber lesioning in rat brain is associated with an altered behavioral spectrum by histamine H1, H2 and H3 receptor antagonists, thereby implicating histaminergic systems as modulators of noradrenergic systems in brain.
Similar content being viewed by others
References
Arrang JM, M Garbag, JC Lancelot, JM Lecomte, H Pollard, M Robba, W Schunack and JC Schwartz (1987) Highly potent and selective ligands for histamine H3-receptors.Nature 327, 117–123.
Bortel A, P Nowak, J Dabrowska and R Brus (2006) Neonatal lesion of the noradrenergic system modifies anxiety-like behavior and GABAergic neurotransmission in the prefrontal cortex of adult rats.Pharmacol. Rep. 58, 294–295. (Abstr.)
Brus R, RM Kostrzewa, KW Perry and RW Fuller (1994) Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.J. Pharmacol. Exp. Ther. 268, 231–237.
Dabrowska J, P Nowak and R Brus (2007) Desensitization of 5-HT1A autoreceptors induced by neonatal DSP-4 treatment.Eur. Neuropsychopharmacol. 17, 129–137.
File SE and JH Pope (1974) The action of chlorpromazine on exploration in paired rats.Psychopharmacol. 37, 249–254.
Gulot-Marnay C, A Lafitte, JM Arrang and JC Schwartz (1989) Modulation of histamine release and synthesis in the brain mediated by α2-adrenoreceptors.J. Neurochem. 53, 513–518.
Hough LB, SD Glick and K Su (1985) Cimetidine penetrates brain and inhibits non-opiate footshock-induced analgesia.Pharmacol. Biochem. Behav. 24, 1257–1261.
Jaim-Etheverry G and LM Zieher (1980) DSP-4: a novel compound with neurotoxic effect on noradrenergic neurons of adult and developing rats.Brain Res. 188, 513–523.
Jochem J (2004) Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats.Naunyn- Schmiedeberg ’ Arch. Pharmacol.369, 418–427.
Kostrzewa RM and RE Garey (1977) Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6 hydroxydopa.Brain Res. 124, 385 391.
Kostrzewa RM and L Gong (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA.Pharmacol. Biochem. Behav. 39, 677–682.
Magnusson O, LB Nilsson and D Westerlund (1980) Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography- electrochemical detection system.J. Chromatogr. 221, 237–247.
Nakamura K and H Theonen (1972) Increased irritability, a permanent behavior change induced in the rat by intracerebrovascular administration of 6-hydroxydopamine.Psychopharmacol. (Berl.) 24, 359–372.
O’ Callaghan JP and SG Holtzman (1975) Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.J. Pharmacol. Exp. Ther. 192, 497–505.
Oswiecimska J, A Sokola and R Brus (1998) Comparison of some central effects of two dopamine agonists, quinpirole and 7-OH-DPAT, in rats.Pol. J. Pharmacol. 50, 173–174.
Ross SB (1976) Long-term effect of N-2-chlorethyl-N-ethyl- 2-brombenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart.Br. J. Pharmacol. 50, 521–527.
Ross SB and AL Renyi (1976) On the long-lasting inhibitory effect of N-(2-chloethyl)-N-ethyl-2-brombenzyl amine (DSP-4) on the active uptake of noradrenaline.J. Pharm. Pharmacol. 28, 458–459.
Schlicker E and I Marr (1997) Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain.Neuroscience 79, 247–254.
Suzuki T, T Mori, M Tsui, M Nomura, M Misawa and K Onodera (1999) Evaluation of the histamine H1-antagonist- induced place preference in rats.Jpn. J. Pharmacol. 81, 332–338.
Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.Psychopharmacology (Berl.) 101, 431–447.
Author information
Authors and Affiliations
Corresponding author
Additional information
Part of this study was presented during IIIrd Neurotoxicity Society Meeting, March 23–25, Pucon, Chile.
Rights and permissions
About this article
Cite this article
Nowak, P., Jochem, J., Zwirska-Korczala, K. et al. Ontogenetic noradrenergic lesion alters histaminergic activity in adult rats. neurotox res 13, 79–83 (2008). https://doi.org/10.1007/BF03033559
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033559